Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Harvard Business School
Teva
Cantor Fitzgerald
Mallinckrodt
Julphar
AstraZeneca
Cipla
Daiichi Sankyo

Generated: October 22, 2017

DrugPatentWatch Database Preview

Oxycodone - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxycodone and what is the scope of oxycodone freedom to operate?

Oxycodone
is the generic ingredient in six branded drugs marketed by Collegium Pharm Inc, Novel Labs Inc, Mayne Pharma Inc, West-ward Pharms Int, Wes Pharma Inc, Mallinckrodt Inc, Vintage Pharms, Alvogen Malta, Hi-tech Pharmacal, Ascent Pharms Inc, Ken Lifescience, Pharm Assoc, Lannett Holdings Inc, Roxane, Lehigh Valley, Actavis Elizabeth, Vistapharm, Amneal Pharms, Ani Pharms Inc, Wockhardt Bio Ag, Sun Pharm Inds Inc, Aurolife Pharma Llc, Epic Pharma Llc, Purdue Pharma Lp, Avanthi Inc, Daiichi Sankyo Inc, Egalet Us Inc, Nesher Pharms, Rhodes Pharms, and Abhai Llc, and is included in forty-five NDAs. There are thirty-nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Oxycodone has fourteen patent family members in five countries and one supplementary protection certificate in one country.

There are seventeen drug master file entries for oxycodone. Two suppliers are listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: oxycodone

US Patents:39
Tradenames:6
Applicants:30
NDAs:45
Drug Master File Entries: see list17
Suppliers / Packagers: see list2
Bulk Api Vendors: see list14
Clinical Trials: see list346
Patent Applications: see list5,152
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxycodone at DailyMed

Pharmacology for Ingredient: oxycodone

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

Tentative approvals for OXYCODONE

Applicant Application No. Strength Dosage Form
u► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
u► Subscribe80MGTABLET, EXTENDED RELEASE; ORAL
u► Subscribe40MGTABLET, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Collegium Pharm Inc
XTAMPZA ER
oxycodone
CAPSULE, EXTENDED RELEASE;ORAL208090-003Apr 26, 2016RXYesNo► Subscribe► SubscribeY ► Subscribe
Mallinckrodt Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL076758-003Mar 19, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-007Apr 5, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-007Apr 5, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-007Apr 5, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
Avanthi Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL091393-001Aug 31, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Daiichi Sankyo Inc
ROXYBOND
oxycodone hydrochloride
TABLET;ORAL209777-003Apr 20, 2017RXNoNo► Subscribe► SubscribeY ► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-005Apr 5, 2010RXYesYes► Subscribe► SubscribeY ► Subscribe
Collegium Pharm Inc
XTAMPZA ER
oxycodone
CAPSULE, EXTENDED RELEASE;ORAL208090-003Apr 26, 2016RXYesNo► Subscribe► Subscribe ► Subscribe
Purdue Pharma Lp
OXYCONTIN
oxycodone hydrochloride
TABLET, EXTENDED RELEASE;ORAL022272-007Apr 5, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: oxycodone

Country Document Number Estimated Expiration
Canada2569958► Subscribe
European Patent Office1765292► Subscribe
European Patent Office1594467► Subscribe
World Intellectual Property Organization (WIPO)2005123039► Subscribe
Japan2013216707► Subscribe
Canada2491572► Subscribe
Japan2009298822► Subscribe
Japan2017101075► Subscribe
Australia2003247876► Subscribe
Japan4694207► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: OXYCODONE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
292Luxembourg► SubscribePRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
US Army
Cantor Fitzgerald
McKesson
UBS
Harvard Business School
Chubb
Healthtrust
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot